Rheological characterization confirmed that incorporation of either TZP or Sema did not significantly alter the mechanical properties of the hydrogel, supporting formulation flexibility and robustness
GLP-1Rs are expressed in the pancreas, intestinal intraepithelial lymphocytes, myocardium, adipose tissue, kidney, liver, blood vessels, lungs and in the CNS.2,3 Although GLP-1 is known for its incretin effect, which it shares with glucose-dependent insulinotropic peptide (GIP), the intake-regulating action, essential for its efficacy against obesity, occurs through its interaction with receptors located in the CNS.1,5 The GLP-1 peptide can reach the central nervous system (CNS) via peripheral vagal afferents, which transmit its action through the nodose ganglion to the nucleus tactus solitarius (NTS)
Glucagon-like peptide 1 and atrial natriuretic peptide in a female mouse model of obstructive pulmonary disease
Am J Physiol Heart Circ Physiol (2020) 318(1):H72h77